Collection of samples for lumefantrine / desbutyl-lumefantrine pharmacology analysis

These guidelines aim to standardize the sample collection procedure during clinical studies of lumefantrine / desbutyl-lumefantrine antimalarial drugs
Publication Version
2.0
Publication Code
CL19
Procedure Author
Chris Lourens

The purpose of this document is to standardize the sample collection procedure during clinical studies of lumefantrine / desbutyl-lumefantrine antimalarial drugs. This should be considered as a recommendation or as a definition of minimum requirements, created by WWARN, aiming to achieve homogeneous quality in the pre-analytical phase of studies and to provide guidelines in the processes of collection, processing, preserving, storage, shipment and safe handling of samples from human origin.